key: cord-0020452-78b9udw6
authors: López-Cortés, Andrés; Abarca, Estefanía; Silva, Leonardo; Velastegui, Erick; León-Sosa, Ariana; Karolys, Germania; Cabrera, Francisco; Caicedo, Andrés
title: Identification of key proteins in the signaling crossroads between wound healing and cancer hallmark phenotypes
date: 2021-08-26
journal: Sci Rep
DOI: 10.1038/s41598-021-96750-5
sha: e4ddc77006de605423a86bdbcda9d011587f6365
doc_id: 20452
cord_uid: 78b9udw6

Wound healing (WH) and cancer seem to share common cellular and molecular processes that could work in a tight balance to maintain tissue homeostasis or, when unregulated, drive tumor progression. The “Cancer Hallmarks” comprise crucial biological properties that mediate the advancement of the disease and affect patient prognosis. These hallmarks have been proposed to overlap with essential features of the WH process. However, common hallmarks and proteins actively participating in both processes have yet to be described. In this work we identify 21 WH proteins strongly linked with solid tumors by integrated TCGA Pan-Cancer and multi-omics analyses. These proteins were associated with eight of the ten described cancer hallmarks, especially avoiding immune destruction. These results show that WH and cancer's common proteins are involved in the microenvironment modification of solid tissues and immune system regulation. This set of proteins, between WH and cancer, could represent key targets for developing therapies.

According to the Genomics Data Commons of the National Cancer Institute (https:// portal. gdc. cancer. gov/), and the cBioPortal database (http:// www. cbiop ortal. org/) 22, 23 , the copy number variant (CNV) amplifications and CNV deep deletions were identified using GISTIC2.0, a computational approach that facilitates sensitive and confident localization of CNV in human cancers 24 ; the inframe, truncating and missense driver mutations were identified through whole exome sequencing; the mRNA high and mRNA low alterations were analyzed through RNA sequencing V2 RSEM where the expression Z-scores of tumor samples were compared to the expression distribution of all log-transformed mRNA expression of adjacent normal samples in each cohort 25 ; and the high and low protein expressions were measured by reverse-phase protein array (RPPA) 26 . Subsequently, we analyzed these genomic, transcriptomic and proteomic alterations belonging to WH genes/proteins of 10,711 individuals with 28 different cancer types.

To generate the OncoPrint encompassing the most significantly altered WH genes/proteins we: (1) calculated the number of alterations per gene and per TCGA Pan-Cancer type; (2) normalized the frequency of alterations dividing the number of alterations per gene by the number of individuals per each cancer cohort; (3) calculated the mean frequency per gene and per alteration type considering all Pan-Cancer types; (4) identified the most altered WH genes/proteins taking into account as a cutoff the mean frequency of all genes/proteins; and (5) validated the most significantly altered WH genes/proteins comparing the alteration frequencies between the group of genes/proteins with the highest alteration frequencies (cutoff > mean frequency) versus the group of genes/proteins with the lowest alteration frequencies (cutoff < mean frequency) by using the Mann-Whitney U test (P < 0.001). Lastly, we applied the Bonferroni correction test (P < 0.001) to perform a multiple comparison between 6) the whole TCGA Pan-Cancer alterations, and 7) the TCGA Pan-Cancer types.

Patient-derived xenografts. With the aim of generating a deeper understanding about the underexpression and overexpression of WH genes in a given tissue, we analyze their behavior in vivo by using bioinformatic resources. The Jackson Laboratory PDX resource (http:// tumor. infor matics. jax. org/% 20mtb wi/ pdxSe arch. do) comprises 455 PDX models originating from 34 different primary sites 27 www.nature.com/scientificreports/ characterized to identify copy number variants, somatic mutations, and transcriptional profiles. Here, we analyzed the expression levels of the 347 WH genes taking into account Z-scores ≥ 2 as overexpressed genes and Z-scores ≤ − 2 as underexpressed genes in the PDX lineages. The gene expression is displayed as a Z-score which measures each gene's model-specific expression in comparison with that gene in all models assayed by the same platform. Additionally, we have calculated a two-tailed P-value per each gene Z-score and have visualized the Z-score distribution of the transcriptional profile in a plot. Lastly, all overexpressed (Z-score ≥ 2) and underexpressed genes (Z-score ≤ − 2) with significant P-values (P < 0.05) encompassed the WH genes from the patientderived xenograft approach.

Wound healing protein-protein interactome network. In order to identify the most essential protein interactions, a WH protein-protein interactome (WH-PPi) network was created by using the human proteome of the Cytoscape StringApp, taking into account zero node addition and the highest confidence interactions (cutoff = 0.9) related to experiments, databases, and co-expression 28, 29 . The degree of centrality represents the number of edges the nodes have in a network [30] [31] [32] , and this centrality index was calculated using the CytoNCA app 33 . Nodes and edges were organized through the organic layout, and the WH-PPi network was visualized through the Cytoscape software v.3.7.1 34 . Lastly, the interactome network analysis considered all WH proteins with at least one high-confidence interaction (cutoff = 0.9) in the human proteome.

Regarding the cancer driver proteins encompassing the WH-PPi network, we compared the degree centrality between the cancer driver nodes and the wound healing nodes by using the Mann-Whitney U test (P < 0.001) in order to determine a correlation between both groups of proteins.

Shortest paths from wound healing proteins to cancer hallmark phenotypes. CancerGenNet (https:// signor. uniro ma2. it/ Cance rGene Net/) is a resource that links proteins that are frequently altered in all cancer types to cancer hallmark phenotypes 35 . This bioinformatic tool, curated by SIGNOR 36 , is based on experimental information that allows to infer likely paths of causal interactions linking proteins to cancer phenotypes. According to Iannuccelli et al. 35 , the shortest paths from proteins to cancer phenotypes were programmatically implemented using the shortest path function of igraph R package, obtaining a distance score. Hence, we analyzed the distance score of shortest paths from wound healing proteins to cancer hallmark phenotypes. Positive regulations were calculated for tumor-promoting inflammation, inducing angiogenesis, cell differentiation, reprogramming of energy metabolism, activating invasion and metastasis, and sustaining proliferative signaling to better understand the signaling crosstalk between wound healing proteins and cancer hallmarks, and negative regulations were calculated for resisting cell death. Additionally, we performed the multiple comparison test as Bonferroni correction (P < 0.001) to compare the mean of the distance score of shortest paths across seven cancer hallmark phenotypes.

Functional enrichment analysis. The functional enrichment analysis gives curated signatures of protein sets generated from omics-scale experiments 37 . Therefore, we performed the functional enrichment analysis of the most altered WH proteins identified through multi-omics approaches (PCA, PDXs, WH-PPi network, and shortest paths to cancer phenotypes). The enrichment was analyzed using g:Profiler version e101_eg48_ p14_baf17f0 (https:// biit. cs. ut. ee/ gprofi ler/ gost) to obtain significant annotations (Benjamini-Hochberg FDR q < 0.001) related GO biological processes, the Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathways, and Reactome signaling pathways 38-40 . Statistical analyses. We performed a multiple comparison test using the Bonferroni correction (significant level of P < 0.001 and a 95% confidence interval) to analyze: (1) significant differences of genomic, transcriptomic and proteomic alteration frequencies across alteration types (mRNA high, mRNA low, CNV amplification, CNV deep deletion, protein high, protein low, driver mutation, and fusion gene), and (2) significant differences of genomic, transcriptomic and proteomic alteration frequencies across 28 TCGA Pan-Cancer types. We also validated the most significant WH genes/proteins that encompassed the OncoPrint comparing the alteration frequencies above and below the cutoff by using the Mann-Whitney U test (P < 0.001). The significance of gene expression in patient-derived xenografts was considered by using Z-scores and P-values. Therefore, genes with Z-score ≥ 2 and two-tailed P < 0.05 mean significant overexpression, and genes with Z-score ≤ − 2 and two-tailed P < 0.05 mean significant underexpression. The WH-PPi network takes into account the highest confidence interactions (cutoff = 0.9). We validated the nodes encompassing the WH-PPi network comparing the degree centrality of them with the cancer driver proteins by using the Mann-Whitney U test. Additionally, we calculated the mean of the distance score of the shortest paths across cancer hallmark phenotypes by using the Bonferroni correction as a multiple comparison test (P < 0.001). Lastly, the functional enrichment analysis of the key proteins in the signaling crossroad between cancer hallmarks and wound healing was performed using g:Profiler that determines the most significant GO: biological processes, KEGG signaling pathways, and Reactome signaling pathways with Benjamini-Hochberg FDR q < 0.001.

OncoPrint of genomic and proteomic alterations according to the TCGA Pan-Cancer Atlas. We have identified 212,459 genomic, transcriptomic and proteomic alterations in the 347 WH genes/ proteins belonging to 10,711 individuals with 28 different TCGA Pan-Cancer types. Figure 1 Ranking of the most altered wound healing genes/proteins (n = 125) taking into account the mean frequency of alterations (cutoff = 0.0075). Lastly, the list includes 21 cancer driver proteins. Lastly, the OncoPrint was performed by using data from the cBioPortal platform (https:// www. cbiop ortal. org/) 22 www.nature.com/scientificreports/ The most common alteration type with a f mean of 0.0432 was mRNA high, followed by CNV amplification (0.0082), mRNA low (0.0028), CNV deep deletion (0.0027), protein high (0.0012), protein low (0.0007), driver mutations (0.0007), and fusion gene (0.0003). We performed the Bonferroni correction as a multiple comparison test to obtain significant alterations (P < 0.001) through the TCGA Pan-Cancer types. Therefore, we detected that mRNA high and CNV amplification were significantly altered (P < 0.001) across all genomic, transcriptomic, and proteomic alterations ( Fig. 2A and Supplementary Table 11 ). Additionally, genes/proteins with the highest alteration frequencies were PTGER4, SCNN1G, and ARFGEF1 with mRNA high alterations; PTGER4, KNG1, and PRAD3 with CNV amplifications; SMAD3, PRSS56, and TOR1A with mRNA low alterations; BLK, GATA4, and DMTN with CNV deep deletions; EGFR, SERPIND1, and ERBB2 with protein high alterations; PRSS56, STXBP3, and MTOR with protein low alterations; PRSS56, NF1, and SMAD3 with truncating, inframe and missense driver mutations; and, NF1, ERBB2, and ARHGAP35 with fusion genes. The complete information of alteration frequencies per gene has been detailed in Fig. 2B and Supplementary Table 11 . Figure 2C shows the TCGA Pan-Cancer types with the highest means of alteration frequencies into WH genes/proteins. ESCA was the cancer type with the highest alteration frequency mean (f = 0. Additionally, we performed the Bonferroni correction as a multiple comparison test to obtain the most significantly altered TCGA Pan-Cancer types (P < 0.001). For instance, ESCA was the most significantly altered (P < 0.001), and GBM was the less significantly altered (P < 0.001) TCGA Pan-Cancer type. Lastly, the complete information of Bonferroni correction results across TCGA Pan-Cancer types is detailed in Fig. 2C Patient-derived xenografts. PDXs are in vivo models of human cancer types engrafted in mouse hosts for translational cancer research and therapy selection for individual patients 27 . We analyzed the gene expression levels of 347 proteins related to the wound healing term (GO:0042060). Figure 3A shows a heatmap of transcriptional expression where 119 WH genes were overexpressed (Z-score ≥ 2) and/or underexpressed (Z-score ≤ − 2) in 25 cancer types. Figure 3B shows a plot of distribution of the transcriptional profile of the 119 WH genes considering their Z-scores and two-tailed P-values. Of them, 33 were significantly overexpressed WH genes (P < 0.05), 47 were significantly underexpressed WH genes (P < 0.05), and 39 were both significantly overexpressed and underexpressed WH genes (P < 0.05). Regarding cancer drivers, we identified to CDKN1A, ERBB2, FLNA, MTOR, NF1, NFE2L2, SDC4, SMAD4, MYH9, NOTCH2, PTEN, GNA13, HIF1A, NACA , and GNAS as significantly expressed genes. Lastly, the overall analysis revealed 119 (34%) WH genes with significant expression in PDXs as detailed in the Supplementary Tables 13, 14, 15.

Wound healing protein-protein interactome network. Figure 4 shows the WH-PPi network with a degree centrality mean of 11.2. KNG1, VWF, FGG, FGA, FN1, FGB, F2, VEGFA, F5, and TGFB1 were the top ten WH proteins with the highest degree of centrality. Figure 4 also shows the cancer driver proteins with a degree of centrality mean of 11.3. FN1, PDGFB, HRAS, EGFR, PIK3CB, SYK, CXCR4, PRKCD, KDR, and PTPN6 were the top ten cancer driver proteins with the highest degree of centrality. The comparison of degree centralities between the cancer driver nodes and the wound healing nodes showed a correlation between both networks with a not significant Mann-Whitney U test (P > 0.05). Lastly, the overall analysis revealed 233 (67%) WH proteins with at least one high-confidence interaction (cutoff = 0.9) in the human proteome as detailed in the Supplementary Table 16 .

Shortest paths from wound healing proteins to cancer hallmark phenotypes. We analyzed the 347 WH proteins by using CancerGeneNet software to find the distance score of the shortest paths to cancer hallmark phenotypes according to Iannuccelli et al. 35 . On the one hand, Fig. 5A revealed that the WH proteins had the shortest paths to proliferation (2.42), followed by differentiation (3.25), deregulating cellular energetics (3.43), resisting cell death (3.50), metastasis (3.54), tumor-promoting inflammation (3.56), and angiogenesis (3.87) . The Bonferroni correction test showed that the WH proteins had significantly shorter paths to proliferation phenotype (P < 0.001) in comparison to the other cancer hallmarks. On the other hand, Fig. 5B shows the top ten WH proteins with the shortest paths to cancer hallmarks. MTOR had the shortest path to sustaining proliferative signaling (0.47), TLR4 to differentiation (0.78), HIF1A to deregulating cellular energetics (0.80), PAK1 to resisting cell death (2.27), NFE2L2 to metastasis (0.86), CCL2 to tumor-promoting inflammation (0.73) , and FGF2 to angiogenesis (0.86). Lastly, the overall analysis revealed 121 (35%) WH proteins with shortest paths to cancer hallmark phenotypes as detailed in Supplementary Table 17 . Figure 6A shows a Venn diagram integrating the multi-omics approaches (PCA, PDXs, WH-PPi network, and the shortest paths to cancer hallmark phenotypes), and obtaining the 21 most relevant WH proteins in our study (Supplementary Table 18 ). Subsequently, we performed a functional enrichment analysis of these 21 WH proteins, obtaining 328 GO: biological processes, 10 KEGG signaling pathways, and 5 Reactome signaling pathways as shown in the Manhattan plot of Fig. 6B . The most significant GO: biological processes with Benjamini-Hochberg FDR q < 0.001 were wound healing (GO:0042060, 3.1 × 10 -29 ), response to wound healing (GO:0009611, 1.2 × 10 -27 ), response to stress (GO:0006950, 7.5 × 10 -11 ), hemostasis (GO:0007599, 6.5 × 10 -10 ), blood coagulation (GO:0007596, 6.5 × 10 -10 ), platelet activation (GO:0030168, 1.5 × 10 -9 ), among others. The most significant KEGG signaling pathways were pathways in cancer (KEGG:05200, 7. Fig. 7 and Supplementary Table 17 . Tables 19 and  21) . Lastly, Fig. 7 details the key proteins in the signaling crossroad between cancer hallmark phenotypes and wound healing. 

Proteins involved in cancer hallmarks may play a crucial role in WH processes and vice versa, mediating tumor progression or tissue reconstitution. The identification of these proteins and understanding how they work in cancer or WH, could lead to new therapeutic approaches. We identify a set of 21 proteins that control processes related to the cancer hallmarks and WH. Interestingly, TCGA Pan-Cancer types with the highest means of alteration in WH proteins are carcinomas, solid tumors of epithelial origin. Non-solid tumors, such as leukemia, do not show a high alteration mean for WH proteins. Evidence shows that leukaemias and solid tumors could Figure 7 . Key proteins involved in both hallmarks of cancer and hallmarks of wound healing. Additionally, each protein set was ranked according to the shortest paths from wound healing proteins to cancer hallmark phenotypes. Path scores of positive regulation were considered for evading growth suppressors, sustaining proliferative signaling, deregulating cellular energetics, inducing angiogenesis, activating invasion and migration, and wound-promoting inflammation; path scores of negative regulation were considered for resisting cell death; and avoiding immune destruction does not show path score information. www.nature.com/scientificreports/ have a common hierarchical organization in terms of carcinogenesis, being originated from a cancer stem cell with sustained self-renewing capacities, which gives rise to other cells with a distinct phenotype, generating cell diversity 41 . Even if a cancer stem cell or a cell-of origin of cancer could exist among solid and non solid-tumors, cells could diverge from these progenitors and develop characteristics associated with their tissue of origin [42] [43] [44] [45] [46] . In this sense, the identified non-solid tumors could maintain or develop the use of WH proteins as support for their progression, modifying the tumor microenvironment, perturbing normal WH processes [47] [48] [49] . Leukemic cells have completely different ways of interacting with their environment thus, not using the WH-healing proteins found in solid-tumors 50 . Among the alterations with the highest frequency mean, we found that mRNA high and CNV amplification were the most represented in the 347 WH genes/proteins analysed through the TCGA Pan-Cancer Atlas. Cancer is characterized by many genomic variations where a close correlation between CNVs and differential gene expression have a qualitative relationship with its downstream effect, especially for oncogenes and tumor suppressor genes 51 . The trend observed by Shao et al., through the analysis of the copy number and mRNA expression data of Broad-Novartis Cancer Cell Line Encyclopedia (CCLE), NCI-60 and TCGA, showed similarities with our study regarding the mRNA high and CNV amplification frequency in solid tumors. Similarly, CNVs change the expression levels of genes located in the concerned genomic region 52 . However, a different set of genes were identified among studies due to the focus of our work in WH genes associated in cancer. Understanding the relationship between WH genes in cancer, their CNV (in germ cells), CNA (in somatic cells) and gene expression characteristics could help in the development of better diagnostic tools and therapeutics 52, 53 .

Recently, processes involved in cell survival and proliferation that might apply to both cancer and WH have been proposed as converging hallmarks, grouping common pathways of regulation and activation. In particular, eight of the ten recognized cancer hallmarks proposed by Hanahan and Weinberg have been related with WH processes 4 . We used these eight recently proposed wound healing hallmarks to classify groups of genes/ proteins that participate in WH (Fig. 7) . "Avoiding immune destruction" (15 proteins), "resisting cell death" (14 proteins), and "activating invasion and migration" (14 proteins) were the hallmarks with the most identified proteins. In wound healing, avoiding immune destruction and resisting cell death, could be linked to a stress resilient mechanism, helping cancer cells to be detected and killed by immune detection and the collateral damage of reactive oxygen species released by immune cells 4, 54 . The large number of proteins grouped on avoiding immune cells could be associated with a reduction in the pro-inflammatory activity in the tumor. This could be related to the regulation of the inflammatory phase in wound healing, whereas in cancer it is more involved in the down-regulation of immune recognition and increased immune escape 2 . On the other hand, only one protein, ERBB2, was associated with the proposed WH hallmark of "deregulating cellular energetics, " interestingly common to all hallmarks of wound healing except "wound promoting inflammation". However, it is well known that normal proliferating cells such as the ones involved in wound healing exhibit a metabolic switch from oxidative phosphorylation to an aerobic glycolytic pathway as seen in the 'Warburg effect' in cancer cells [55] [56] [57] . Previous transcriptomic analysis revealed metabolic heterogeneity in wounded mouse skin with an increased expression of proteins associated with glycolysis and a reduction of transcripts linked to oxidative phosphorylation 58 . In addition, some of the identified genes in this work code for proteins such as mTOR which has an important role in mediating changes in cellular metabolism and promoting glycolysis 57, 59 . Even though WH is a natural physiological process for tissue repair, and cancer involves an abnormal state, the common mTOR expression is proposed to facilitate the uptake of nutrients demanded for cell growth and proliferation in both processes 55 .

We identified 21 WH proteins in the majority of cancer/WH hallmarks, we found among the most represented: ANXA1 and NOTCH2 (found in 7 of 8 hallmarks, excluding "deregulating cellular energetics"), ERBB2 (found in 7 of 8 hallmarks, excluding "wound promoting inflammation"), mTOR and VEGFA (found in 6 of 8 hallmarks, excluding "deregulating cellular energetics" and "wound promoting inflammation"), HMGB1 (found in 6 of 8 hallmark, excluding "evading growth suppressors" and "deregulating cellular energetics"), FLNA (found in 4 of 8 hallmarks, excluding "inflammation", "evading growth suppressor", "avoiding immune destruction" and "deregulating cellular energetics"), and YAP1 (found in 4 of 8 hallmarks, excluding "deregulating cellular energetics, "inflammation", "angiogenesis" and "activating invasion and migration". The identification of these WH proteins involved in most of the cancer/WH hallmarks represent a major opportunity to understand how the regulation of the WH would be applied to stop cancer growth.

These proteins common to most of the cancer/WH hallmarks are associated with proliferation and migration processes both key for WH and cancer progression. The Notch signaling pathway is evolutionarily conserved among multicellular organisms regulating stem cell maintenance, cell proliferation, differentiation, and apoptosis [59] [60] [61] . These key effects are important for the control of cancer and proper stimulation of the WH process 62 . In mammals, one of the four types of Notch proteins, NOTCH2 promotes angiogenesis with an important role in the carcinogenesis process. Interestingly, it has been observed that NOTCH1 controls NOTCH2, thus acting as a tumor suppressor. NOTCH2 promotes immune activation and inflammations modulating macrophages phenotype 63, 64 . The proinflammatory role of NOTCH2 is detrimental for the healing of diabetic wounds, being an interesting target of molecules with regenerative properties 65, 66 .

ERBB2 plays a crucial role in cell proliferation, epithelial differentiation and WH 67 . It has been reported that ERBB2 promotes tumor progression especially in skin and breast cancers 68, 69 . In wound healing, the ERBB2 activation during the proliferative phase of tissue repair promotes the WH of human airway epithelial cell wounds. The blockage of ERBB2 leads to the failure of the regenerative process. However, blocking ERBB2 could be an important therapeutic target in cancer 67, 70, 71 .

The activity of mTOR, as mentioned before, is considered a central regulator of cell growth, proliferation, cellular metabolism, survival and homeostasis 72, 73 . mTOR plays an important role in the PI3K-AKT signaling pathway involved in WH mechanisms such as growth and proliferation. However, evidence shows that mTOR deregulation is implicated in tumorigenesis and tumor progression. In WH, mTOR improves the wound closure www.nature.com/scientificreports/ rate, being especially active in epithelial cells. The pharmacological activation of PI3K-AKT-mTOR improves WH, influencing its upstream regulators PTEN and TSC1 74 . The deregulation of mTOR is implicated in progression of cancer and the aging process 75 . This research provides more evidence of the important role of mTOR in WH and cancer being a key target for therapy, whether promoting tissue regeneration or by preventing cancer growth when blocked. In the tumor microenvironment and during WH, the physical interaction of fibroblasts with collagen regulate many cellular processes through the activity of FLNA. FLNA is an actin filament cross-linking protein that acts in the regulation of cell adhesion 76 . Several actin-binding proteins, including vinculin, α-actinin, paxillin, talin, cortactin, gelsolin, and filamins provide instructive signals that regulate the maintenance of tension in collagen during remodeling. This is linked to the FLNA function which focuses on mediating cell-induced contraction and wound closure 77, 78 . On the other hand, FLNA can induce two opposite outcomes in cancer depending on its subcellular localization: (1) promoting cell growth and metastasis when it is present in the cytoplasm and interacting with cell signalling molecules, or (2) inhibiting cell growth and preventing metastasis when it is acting in the nucleus and interacting with transcription factors 79 . In cancer, the inhibition of NF1 contributes to the generation of melanomagenesis by enhancing the activation of PI3K signaling, this inhibition favours angiogenesis, escaping apoptosis, migration, and cancer cell invasion [80] [81] [82] [83] .

The YAP1 protein, a precursor of the activity of the YAP/TAZ signaling pathway, is essential for skin homeostasis and WH 84, 85 . YAP1 has been associated with processes such as proliferation and the recruitment of M2 macrophages, myeloid-derived suppressor cells (MDSC), and regulatory T cells to suppress host effector T cells in the tumor microenvironment 86 . YAP1 activity in tumors results in cancer progression and drug resistance 86 . YAP1 contributes to cancer invasion and migration by promoting SNAI2 transcription through the transcription cofactor TEAD, in vivo and in vitro assays. YAP1 expression promotes cell proliferation, migration, and invasion, while silencing YAP1 significantly inhibits cell migration, invasion, and growth 84 . Given that YAP1 is hyperactive in many human cancers, it suggests that therapeutic targeting of YAP1 could regulate key processes in the tumor, thereby disrupting its survival mechanisms 87 .

During the WH process, the inhibition of thrombospondin 1 (TSP-1) and 2 (TSP-2) by HRG promotes angiogenesis facilitaning wound closure 88 . Similarly, ANXA1 promotes the development of blood vessels and metastasis with a deleterious effect in cancer, however positive effects during the WH process 89, 90 .

Among the least represented proteins, we found NFE2L2 and CDKN1A. NFE2L2 is activated after tissue damage and promotes wound repair protecting cells for the damaging effects of ROS production during inflammation 91 . Insufficient NFE2L2 expression impairs WH in a process associated with severe tissue damage and uncontrolled inflammation 92 . Inhibition of NFE2L2 in keratinocytes favors tumor development. In contrast, when NFE2L2 is functional, it plays an important role in reducing cellular stress, preventing DNA damage and cancerous mutations 93 . NFE2L2 expresses a bZIP protein with cytoprotective effects 94, 95 , regulating genes involved in redox homeostasis 56, 96, 97 , this functioning in the stress defense in mammalian cells 98 . However, when NFE2L2 is overexpressed in cancer cells, it promotes their drug and radiotherapy resistance 99 . The CDKN1A gene was initially considered as a potential tumor suppressor. However, studies have reported that this gene could act as an oncogene due to its anti-apoptotic activities 100, 101 . It is involved in p53-mediated inhibition of cell proliferation in response to DNA damage leading to cell cycle arrest at the G1/S checkpoint 102, 103 . By overexpressing CDKN1A, wound fibroblasts enhance age-related healing, creating potential clinical avenues to promote wound healing in the elderly population 104 . Inhibition of this protein can act to enhance the regenerative response in several ways, altering DNA damage and checkpoint responses, leading to increased proliferation. It can reduce TGF-β signaling, which decreases scar formation and would alter differentiation patterns 105 .

This work identified 21 proteins in which eight have shown to be highly associated between WH and the cancer hallmarks. These proteins could represent critical nodes in the network of a controlled WH process or a deregulated interaction leading to tumor progression. Interestingly, the identified proteins were highly expressed only in solid tumors, as cancer cells must use them to modify the tissue microenvironment and induce immune cell regulation. This protein set could be specially needed to reorganize the wounded tissue and lead to regeneration. However, in the case of cancer, these proteins induce immune escape and survival. Putting in evidence these common proteins between WH and cancer brought light to those principally involved in sustained proliferation, invasion, angiogenesis, and others connected and overlapped between health and disease. Further interdisciplinary studies in vivo or in patients will support the in silico role of the identified and overlapped proteins. Interdisciplinarity is important as it brings together specialists in bioinformatics, health care professionals and technical experts leading to the development of better screening methods for early diagnosis and therapies 106 . These studies would allow therapeutic targeting and the development of specific pharmacological compounds that would stop cancer progression without affecting the healing process.

The datasets generated for this study are included in this published article (and its Supplementary Information files).

Gene expression profiles in normal and cancer cells

Hallmarks of cancer: The next generation

When it is time to die

The hallmarks of cancer are also the hallmarks of wound healing

Tumors: wounds that do not heal-redux

Addendum to "molecular repair, wound healing, and carcinogenesis: Tumor production a possible overhealing

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

Epithelial stem cells, wound healing and cancer

Tissue engineering and regenerative repair in wound healing

Mesenchymal stromal cells and cutaneous wound healing: A comprehensive review of the background, role, and therapeutic potential

Wound healing: A cellular perspective

Factors affecting wound healing

The innate immune system, toll-like receptors and dermal wound healing: A review

Skin tissue engineering: Wound healing based on stem-cell-based therapeutic strategies

Gene ontology: Tool for the unification of biology

The Gene Ontology Consortium. The gene ontology resource: 20 years and still going strong

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

A compendium of mutational cancer driver genes

The COSMIC Cancer Gene Census: Describing genetic dysfunction across all human cancers

Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer

Pathogenic germline variants in 10,389 adult cancers

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers

RSEM: Accurate transcript quantification from RNA-Seq data with or without a reference genome

Reverse phase protein arrays-quantitative assessment of multiple biomarkers in biopsies for clinical use

Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): Challenges and guidelines

STRING v10: Protein-protein interaction networks, integrated over the tree of life

Cytoscape stringapp: Network analysis and visualization of proteomics data

Gene prioritization, communality analysis, networking and metabolic integrated pathway to better understand breast cancer pathogenesis

OncoOmics approaches to reveal essential genes in breast cancer: A panoramic view from pathogenesis to precision medicine

In silico analyses of immune system protein interactome network, single-cell RNA sequencing of human tissues, and artificial neural networks reveal potential therapeutic targets for drug repurposing against COVID-19

CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks

Cytoscape: a software environment for integrated models of biomolecular interaction networks

CancerGeneNet: linking driver genes to cancer hallmarks

SIGNOR: a database of causal relationships between biological entities

Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and Enrich-mentMap

Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)

The Reactome pathway Knowledgebase

TCGA pan-cancer genomic analysis of alternative lengthening of telomeres (ALT) related genes

Cells of origin in cancer

The origin and evolution of mutations in acute myeloid leukemia

The cell of origin and the leukemia stem cell in acute myeloid leukemia

Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer

Conversion of stem cells to cancer stem cells: Undercurrent of cancer initiation

Stemness in cancer: Stem cells, cancer stem cells, and their microenvironment

The microenvironment of wound healing

The external microenvironment of healing skin wounds

Dynamic reciprocity in the wound microenvironment

Leukemia stem cells microenvironment

Copy number variation is highly correlated with differential gene expression: A pan-cancer study

Transcriptional effects of copy number alterations in a large set of human cancers

Copy-number-variation and copy-number-alteration region detection by cumulative plots

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy

Understanding the Warburg effect: The metabolic requirements of cell proliferation

Warburg effects in cancer and normal proliferating cells: two tales of the same name

Regulation of glycolysis and the Warburg effect in wound healing

Defining epidermal basal cell states during skin homeostasis and wound healing using single-cell transcriptomics

Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis

The canonical Notch signaling pathway: unfolding the activation mechanism

The varied roles of notch in cancer

Perspectives on the discovery of NOTCH2-specific inhibitors

Regulation of monocyte cell fate by blood vessels mediated by Notch signalling

Notch regulates macrophage-mediated inflammation in diabetic wound healing

Role of Notch signaling in regulating innate immunity and inflammation in health and disease

Wound healing can be improved by (-)-epigallocatechin gallate through targeting Notch in streptozotocininduced diabetic mice

ERBB2 is essential for the growth of chemically induced skin tumors in mice

Coexpression patterns of EGFR, HER2, HER3 and HER4 in non-melanoma skin cancer

Insights from transgenic mouse models of ERBB2-induced breast cancer

Segregation of receptor and ligand regulates activation of epithelial growth factor receptor

Dysfunctional ErbB2, an EGF receptor family member, hinders repair of airway epithelial cells from asthmatic patients

mTOR in health and in sickness

Roles of mTOR signaling in tissue regeneration

Accelerated wound healing by mTOR activation in genetically defined mouse models

mTOR signaling in growth, metabolism, and disease

Filamin A mediates interactions between cytoskeletal proteins that control cell adhesion

Filamins as integrators of cell mechanics and signalling

Filamin A mediates wound closure by promoting elastic deformation and maintenance of tension in the collagen matrix

The dual role of filamin A in cancer: Can't live with (too much of) it, can't live without it

The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways

Loss of NF1 expression in human endothelial cells promotes autonomous proliferation and altered vascular morphogenesis

Elucidating distinct roles for NF1 in melanomagenesis

miR-107 regulates tumor progression by targeting NF1 in gastric cancer

YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD

Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine

A time for YAP1: Tumorigenesis, immunosuppression and targeted therapy

Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice

Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1

Role of heregulin in human cancer

Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice

Molecular mechanisms of Nrf2-mediated antioxidant response

Regulation of wound healing by the NRF2 transcription factor-more than cytoprotection

Nrf transcription factors in keratinocytes are essential for skin tumor prevention but not for wound healing

Increased NRF2 gene (NFE2L2) copy number correlates with mutations in lung squamous cell carcinomas

Transcription factor NFE2L2/NRF2 modulates chaperone-mediated autophagy through the regulation of LAMP2A

Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1

Molecular mechanisms and systemic targeting of NRF2 dysregulation in cancer

Activating de novo mutations in NFE2L2 encoding NRF2 cause a multisystem disorder

Targeting NFE2L2, a transcription factor upstream of MMP-2: A potential therapeutic strategy for temozolomide resistant glioblastoma

The role of the cyclin-dependent kinase inhibitor p21 in apoptosis

Association between p21 Ser31Arg polymorphism and cancer risk: A meta-analysis

p21 (CDKN1A) is a negative regulator of p53 stability

Loss of p21 permits carcinogenesis from chronically damaged liver and kidney epithelial cells despite unchecked apoptosis

Local and transient inhibition of p21 expression ameliorates age-related delayed wound healing

The role of p21 in regulating mammalian regeneration

Breast cancer, screening and diagnostic tools: All you need to know

Kyoto encyclopedia of genes and genomes

This work was supported by the Latin American Society of Pharmacogenomics and Personalized Medicine (SOLFAGEM). We thank the School of Medicine at the Universidad San Francisco de Quito, USFQ for their constant support of our work and initiatives. We are grateful to Vice-Rectorate for Research, the Directorate of the Life Sciences Area and the Biotechnology Career of Universidad Politécnica Salesiana for the support given in this investigation.We are thankful to the "Corporación Ecuatoriana para el Desarrollo de la Investigación y Académica, CEDIA" for the financial support provided to our project CEPRA XIV-2020-04, MITOCHONDRIAS, promoting the development of research and innovation in Ecuador.

A.L.-C. and A.C. conceived the subject and the conceptualization of the study. A.L.-C., E.A., L.S., E.V., A.L.-S., and A.C. wrote the manuscript. E.A., L.S., E.V., A.L.-S., G.K., and F.C. edited the manuscript, did data curation, and gave valuable scientific input. A.L.-C., G.K., F.C., and A.C. did funding acquisition. Lastly, all authors reviewed and approved the manuscript.

Publication of this article was funded by Universidad UTE, Universidad Politécnica Salesiana UPS, and Universidad San Francisco de Quito USFQ by the project's enregistrer in the HUBi database with the ID: 12468, 16925, 16999.

The authors declare no competing interests.

The online version contains supplementary material available at https:// doi. org/ 10. 1038/ s41598-021-96750-5.Correspondence and requests for materials should be addressed to A.L.-C. or A.C.Reprints and permissions information is available at www.nature.com/reprints.Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.